Univ Klinik für Kinder- und Jugendheilkunde
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jones, Neil
NCT01728155: European Low and Intermediate Risk Neuroblastoma Protocol

Completed
3
685
Europe, RoW
chemotherapy
Instituto de Investigacion Sanitaria La Fe
LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES
12/22
 
AIEOP-BFM ALL 2017, NCT03643276 / 2016-001935-12: Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia -

Recruiting
3
5000
Europe, RoW
Blinatumomab, Bortezomib, Cyclophosphamide, Cytarabine, Daunorubicin, Myocet, Dexamethasone, Doxorubicin, Etoposide, Fludarabine Phosphate, Ifosfamide, 6-Mercaptopurine, Methotrexate, Pegaspargase, Prednisolone, Prednisone, Tioguanin, Vincristine, Vindesine, Erwinase
Martin Schrappe, Deutsche Krebshilfe e.V., Bonn (Germany)
Acute Lymphoblastic Leukemia, Pediatric
07/28
07/28
MEMMAT, NCT01356290 / 2010-023691-33: Antiangiogenic Therapy for Children with Recurrent Medulloblastoma, Ependymoma and ATRT

Recruiting
2
100
Europe, US
Bevacizumab, Avastin, Thalidomide, Celecoxib, Fenofibric acid, Etoposide, Cyclophosphamide, Etoposide phosphate, Cytarabine
Medical University of Vienna
Medulloblastoma Recurrent, Ependymoma Recurrent, ATRT Recurrent
04/30
04/30

Download Options